Podcasts about improving outcomes

Ticagrelor vs prasugrel, a new LAAC device, pulsed field ablation AF results, lifestyle intervention in AF, the term "provider" vs "doctor," and coffee are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I TUXEDO-2 Trial TUXEDO-2 Trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2844869 ISAR-REACT 5 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1908973 II VERITAS Study of Dual-Seal LAAO VERITAS Study https://doi.org/10.1016/j.jacep.2026.01.021 III PFA vs RF over 4 years Advent-LTO study https://www.nature.com/articles/s41591-026-04246-4 ADVENT Study https://www.nejm.org/doi/full/10.1056/NEJMoa2307291 SPHERE PER-AF Study https://www.nature.com/articles/s41591-024-03022-6 SINGLE SHOT CHAMPION Study https://www.nejm.org/doi/full/10.1056/NEJMoa2502280 BEAT PAROX-AF Trial https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf1115/8436829 IV What's in a Name — Use of the Term "Provider" Physicians Are Not Providers: The Ethical Significance of Names https://www.acpjournals.org/doi/10.7326/ANNALS-25-03852 V Coffee and Dementia Risk Coffee/Tea Intake and Dementia Risk https://jamanetwork.com/journals/jama/fullarticle/2844764 Mandrola Commentary: Enough With the Coffee Research and Other Distractions https://www.medscape.com/viewarticle/883709 VI Lifestyle interventions Post AF ablation Improving Outcomes of AF by Lifestyle Interventions https://academic.oup.com/eurheartj/article/47/6/669/8243674 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Please visit answersincme.com/YMM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nitish Mehta, MD; and Sarwar Zahid, MD. In this activity, experts in diabetic retinopathy discuss long-acting anti-VEGF agents and strategies to improve outcomes for patients with diabetic macular edema (DME). Upon completion of this activity, participants should be better able to: Recognize factors that contribute to patients' treatment burden with intravitreal anti-VEGF therapies for diabetic macular edema (DME); Assess the clinical profiles of long-acting intravitreal anti-VEGF agents for DME; and Recommend individualized strategies to enhance long-term treatment outcomes for patients with DME.

Please visit answersincme.com/YMM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nitish Mehta, MD; and Sarwar Zahid, MD. In this activity, experts in diabetic retinopathy discuss long-acting anti-VEGF agents and strategies to improve outcomes for patients with diabetic macular edema (DME). Upon completion of this activity, participants should be better able to: Recognize factors that contribute to patients' treatment burden with intravitreal anti-VEGF therapies for diabetic macular edema (DME); Assess the clinical profiles of long-acting intravitreal anti-VEGF agents for DME; and Recommend individualized strategies to enhance long-term treatment outcomes for patients with DME.

Alec Patton talks to Beverley Jenkins and Kate Hogan of the System Improvement Leads Networked Improvement Community and Nicole Leveille of Cloverdale Unified School District about how Cloverdale dramatically increased the percentage of students with IEPs in the general education population, and cut chronic absenteeism among students with disabilities in half. Every other week, we publish a newsletter with great resources like this one, sign up for it here! What are you waiting for, register for the National Summit for Improvement in Education before you miss out! Episode Notes: You can read an article by Kate Hogan and Sandra Park about this improvement network on Unboxed here ! To learn more about the System Improvement Leads (SIL) team and their supports, visit  systemimprovement.org To learn more about California's Compliance and Improvement Monitoring process, visit  caltan.info In partnership with Cloverdale, SIL has published a strategy handout  linked here Learn more about the High Tech High Graduate School of Education

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com What happens when AI meets real-world healthcare challenges? In this episode, Kali Ihde, Director of Northwestern Medicine's Ventures and Innovation, discusses how AI is being practically applied to enhance patient care and operational efficiency. She explains the importance of moving past hype, piloting AI solutions safely, and integrating them into workflows with input from clinicians and administrators. Kali highlights the growing AI literacy among healthcare professionals and shares how agentic AI is helping healthcare providers reach patients for preventive care while identifying risks such as elder abuse or suicidal ideation. She also emphasizes the need for structured evaluation and clear metrics to ensure that results are meaningful. Tune in to hear how Northwestern Medicine is leveraging AI to make a real difference in hospitals, clinics, and communities! Resources Connect with and follow Kali Ihde on LinkedIn. Follow Northwestern Medicine on LinkedIn and discover their website!

CME credits: 0.25 Valid until: 03-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/early-action-in-obesity-transforming-practice-improving-outcomes/36273/ Expert faculty Drs. Luca Busetto and Kirsi H. Pietiläinen discuss the importance of early intervention in obesity management to prevent progression and obesity related complications. They examine the evolving therapeutic landscape, including GLP-1 and GIP-based medications like semaglutide and tirzepatide. The conversation highlights real-world evidence and addresses the shift from weight-centric to holistic clinical approaches, as seen in updated European and Canadian guidelines. Monitoring strategies—including satiety, nutritional status, physical activity, and side effects—are explored as key elements in long-term obesity care. The dialogue underscores the chronic nature of obesity and the importance of patient-centered care. =

Glaucoma is a common eye disease that can cause irreversible blindness. However, it's also becoming increasingly, effectively treatable. Discover Glaucoma: Setting Sights on Improving Outcomes…inside this edition of CTSI Discovery Radio!

Did you know that properly selected music is restoring communication, easing pain, reducing medication use, and transforming dementia care for patients – and their family and caregivers? Discover how personalized music is lowering costs, improving outcomes, and helping families reconnect in meaningful, unforgettable moments – without pharmacological side effects. Bonus Tip: Use holiday music thoughtfully this season to spark connection and joy – without causing overstimulation or stress for your loved ones. Links and notes related to this episode can be found at https://mpetersonmusic.com/podcast/episode222 Connect with us: Newsletter: https://mpetersonmusic.com/subscribe Facebook: https://www.facebook.com/EnhanceLifeMusic/ Instagram: https://www.instagram.com/enhancelifemusic/ LinkedIn: https://www.linkedin.com/in/mpetersonpiano/ X: https://twitter.com/musicenhances Sponsorship information: https://mpetersonmusic.com/podcast/sponsor Leave us a review on Podchaser.com! https://www.podchaser.com/podcasts/enhance-life-with-music-909096 In-episode promo: Sheet Music Direct https://www.sheetmusicdirect.com  

Event Objectives:Identify options for Chiari malformation surgery, craniofacial surgery and epilepsy surgery in children that optimize outcomes while providing less invasive alternatives.Claim CME Credit Here!

Robotic surgery has improved patient recovery. It means smaller incisions and less pain. In most cases- shorter hospital stays. We'll take you inside the O-R and show you the latest technology.

Transferring credits from a community college to a four-year institution remains a crucial strategy to boosting bachelor's degree attainment and improving outcomes for graduates. But transfer students often face significant challenges to having their credits accepted and, more importantly, applied to degree requirements at four-year institutions. Faculty members in teaching, research, and administrative positions play a pivotal role in decisions about whether and how credits transfer. Yet little is known about how they approach these decisions or what factors influence their judgment. MDRC is working with three University of Texas System colleges to better understand how faculty members make these decisions within a large and complex transfer landscape. In this episode, Leigh Parise talks with Marjorie Dorimé-Williams, senior research associate at MDRC, leading the study.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Dr. Beth Mullen-Houser explores how Internal Family Systems (IFS) can help therapists recognize and repair ruptures caused by disconnection. This episode examines the ethical responsibility of staying present and attuned, even when our own internal systems get activated. Interview with Elizabeth Irias, LMFT. Earn CE credit for listening to this episode by joining our low-cost membership for unlimited podcast CE credits for an entire year, with some of the strongest CE approvals in the country (APA, NBCC, ASWB, and more). Learn, grow, and shine with Clearly Clinical Continuing Ed by visiting https://ClearlyClinical.com.

oin i3 Health for a special live webinar, Increasing Detection and Improving Outcomes in Hereditary Transthyretin Amyloid Cardiomyopathy, being held on Wednesday, July 30 at 5:00 pm ET. In this exclusive event, Dr. Mathew Maurer, the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, will share his expertise and latest insights in the treatment of hereditary ATTR-CM. In this interview, Dr. Maurer shares a preview of the topics he is excited to highlight during the webinar, including signs and symptoms to aid in early diagnosis, advances in genetic testing and new diagnostic modalities, novel therapies that are improving outcomes, and the role of interdisciplinary collaboration. Don't miss this opportunity to learn from one of the leading voices in hereditary ATTR-CM care. Register at the link below or scan the QR code in the video to secure your spot. We look forward to seeing you! Register Here: bit.ly/3UgV7nF

Recently the Endocrine Society’s Bone and Mineral Special Interest Group discussed the importance of fracture liaison services and how they contribute to an improved quality of life for patients and cost saving for the facility. An important part of the discussion revolved around a recent perspective published in The New England Journal of Medicine titled, “Coordinating Multidisciplinary Care — Improving Outcomes after Fragility Fractures.” The article notes that despite the benefits of fracture liaison services, the lack of reimbursement for those services in the United States is a significant financial barrier, rendering the service underutilized. The article further states that the global burden of hip fractures is expected to double over the next few decades. Are we looking at an impending crisis? What role should fracture liaison services play in reducing treatment gaps and improving post-fracture care? Host Aaron Lohr talks with the three authors of that New England Journal of Medicine perspective: Nicola Napoli, MD, PhD, associate professor of endocrinology and metabolism at Campus Bio-Medico University of Rome, Italy; Peter Ebeling, AO, professor medicine at Monash University in Melbourne, Vic., Australia; and Douglas P. Kiel, MD, professor of medicine at Marcus Institute for Aging Research at Hebrew Senior Life. Show notes are available at https://www.endocrine.org/podcast/enp99 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Biliary tract cancers are a group of rare cancers with limited treatment options and generally poor outcomes because most patients are diagnosed at an advanced stage. There are efforts to address that through the development of early detection tools. And the use of biomarker testing can today match as many as half of these patients to a targeted therapy, although it's critical to make people aware of the importance of this. We spoke to Rachna Shroff, associate director of clinical investigations of the gastrointestinal clinical research team at the University of Arizona Cancer Center, about biliary tract cancers, the importance of biomarker testing, and what can be done to improve outcomes for people with these rare cancers.

Discover how Kalamazoo Youth Development Network is changing the landscape of youth services in our community. Unlike distant foundations, KYD Net provides hands-on support, valuable assessment tools, and actionable improvement strategies—all at no cost to local programs. What makes their approach so effective? Why do community leaders consider their expertise "priceless"? Join us as three team members from KYD Net reveal their collaborative method for strengthening youth programs and the real-world impact of their work. Learn how this accessible resource is elevating youth development across Kalamazoo and Battle Creek, one program at a time.

In this week's episode of First Case, we sit down with JD Buchert, Director of Workforce Safety at Parkland Health in Dallas, TX, to discuss the unique challenges transgender patients face as they navigate the healthcare setting. Did you know that over 70% of transgender individuals turn to emergency departments for care, often due to discrimination or harassment in other medical spaces? In this powerful discussion, JD highlights the importance of using gender-affirming language and treating each patient with respect, leaving biases at the door. He shares how inclusive care not only improves patient outcomes but also reduces overall healthcare costs. Tune in to learn how to create a safe, compassionate environment for everyone.  #operatingroom #ornurse #surgicaltechnologist #perioperative #perioperativenurse

On this episode of Grow With Us, Evan speaks with Levi Patrick, Executive Director of the Tulsa Regional STEM Alliance. We talk about the community opportunities to positively impact a student in Science, Technology, Engineering, and Mathematics, the impact and reach of TRSA, and the importance of workforce development in education pathways. Join us today! Subscribe on Apple Podcasts and Spotify to get notified of our new releases and share with anyone who wants to learn more about Tulsa!If you are interested in looking at our open career opportunities, don't forget to check out our career website: https://careers.intulsa.com/Join our Talent Network to receive access to the latest job opportunities in Tulsa: https://careers.intulsa.com/user/register/applicantAdditionally, find out about all our upcoming Elevate your Career Series Free Workshop events at talent.intulsa.com/events

In this episode, we speak with Dr. Natalie Lui, Assistant Professor of Cardiothoracic Surgery at Stanford University, about lung cancer screening and the importance of early detection. Since lung cancer is often diagnosed in advanced stages, yearly low-dose computed tomography (LDCT) screening is crucial, especially for heavy smokers. We discuss risk factors, screening criteria from the U.S. Preventive Services Task Force, National Comprehensive Cancer Network, and the American Cancer Society, and why screening isn't universal despite its importance. Additionally, we explore current research, recent updates to guidelines, barriers to screening in underserved communities, and the potential of emerging technologies, such as AI, to enhance lung cancer screening in the future. Read Transcript CME Information: https://stanford.cloud-cme.com/medcastepisode92 Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3122

In this episode of Happy Hour with Bundle Birth Nurses, Sarah Lavonne dives into the journey behind the creation of the Physiologic Birth Class. From working in a highly medicalized L&D unit to later experiencing a contrasting approach in a more affluent hospital, Sarah's nursing career shaped her vision for promoting physiologic birth. Driven by a desire to empower nurses, she designed this class to equip them with the knowledge and hands-on skills essential for supporting physiologic labor and birth. Thousands of nurses have since been trained and seen the impact on their practice while enhancing birth outcomes, decreasing cesarean rates, reducing trauma, and reshaping the culture of obstetric care. Sarah underscores the power of a nurse's deep understanding of birth physiology to provide truly patient-centered care. Helpful Links:Sign up for our most popular Physiologic Birth ClassMotion takes all the concepts taught in class and practically applies them to your practiceWe train hospitals! Drop your manager's info hereSign up for our monthly newsletter for news & free educationCheck out our physical products that you can use to apply to your physiologic birth practice

Featuring perspectives from Prof Francois-Clement Bidard and Dr Kevin Kalinsky, including the following topics: Introduction: Confronting Metastatic Breast Cancer (mBC) (0:00) Mechanisms of Resistance to Endocrine Therapy in HR-Positive mBC; Use of Oral Selective Estrogen Receptor Degraders (SERDs) — Dr Kalinsky (13:18) Ongoing Evaluation of Early Therapeutic Switching for HR-Positive mBC Harboring ESR1 Mutations — Prof Bidard (35:52) CME information and select publications

Prof Francois-Clement Bidard from Institut Curie in Paris and Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta discuss improving the outcomes of first-line endocrine-based therapy for patients with HR-positive, HER2-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/FirstLineTherapymBC24).

Prof Francois-Clement Bidard from Institut Curie in Paris and Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta discuss improving the outcomes of first-line endocrine-based therapy for patients with HR-positive, HER2-negative metastatic breast cancer.

How often have you been asked to apply abdominal pressure during a colonoscopy? This practice isn't just tough on the team—it also poses serious risks to both the staff and the patient. Join us in this First Case Vendor SpotlightTM as we learn about colonoscopies and as we explore the very real dangers of manually applying abdominal pressure. In this eye-opening conversation, James Hathorn, CEO and Founder of ColoWrap®, highlights a common complicating factor in colonoscopy, scope looping, that results in up to 1 in 3 procedures that either aren't completed or are completed while putting the patient and caregiver at risk. Plus, discover the only safe, proven looping solution on the market that is non-invasive and easy to use.   ColoWrap® was developed by a high-volume clinical gastroenterologist and is the first clinical solution to mitigate the need for manual abdominal pressure during colonoscopy. ColoWrap® improves throughput, reduces cecal intubation time, and empowers organizations to deliver a safer environment for patients, staff, and providers. To learn more about ColoWrap®, go to www.colowrap.com/firstcase  You can also follow them on Facebook and LinkedIn!   #operatingroom #colonoscopy #vendorspotlight #ornurse #nurse #scrubtech #endoscopy

Please visit answersincme.com/RKX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in skin cancer discusses strategies for adjuvant immunotherapy in resectable melanoma. Upon completion of this activity, participants should be better able to: Review the guideline-recommended role of adjuvant immunotherapy for the treatment of resectable melanoma; Describe the key adverse events associated with adjuvant immunotherapy for the treatment of resectable melanoma; Outline evidence-based, patient centric strategies to optimize the benefit-to-risk impact of adjuvant immunotherapy in resectable melanoma care

Neurodegenerative diseases such as Parkinson's, Alzheimer's, Multiple Sclerosis, ALS, are “chronic conditions that damage and destroy parts of your nervous system over time, especially your brain.” According to mainstream medicine, “these conditions are permanent and incurable, but many are now treatable thanks to medical advances. Currently, the main goal is to treat the symptoms and slow the progress of these conditions when possible”.  We also know that neurodegenerative disorders are the leading cause of physical and cognitive disability around the globe, affecting 15% of the world population, and are expected to double over the next two decades. Given that neurological disorders are so prevalent and on the rise, and given that mainstream medicine has few options other than symptom management, it is vital for the prevention and reversal of neurodegenerative disease to look elsewhere. Integrative and Functional Medicine has a lot more answers to neurodegeneration than mainstream medicine, and Dr. Ken Sharlin is a neurologist who has transformed his conventional neurology practice to incorporate more integrative and functional medicine approaches into his practice for better patient outcomes.  In this episode of the MindHealth360 Show, we are joined by Dr. Ken Sharlin, author of *The Healthy Brain Toolbox*, who shares his journey from conventional neurology to a more holistic practice, emphasising the importance of addressing lifestyle, environmental factors, and personalised medicine in treating conditions like Parkinson's, Alzheimer's and MS. Dr. Sharlin discusses how modern neurology has traditionally focused on diagnosis and limited treatment options, often missing the opportunity to explore and address the root causes of neurological diseases. He explains that while medications and surgeries are valuable, they represent only a portion of the available tools. By incorporating functional medicine principles, including therapeutic lifestyle changes, environmental toxin mitigation, and addressing metabolic syndromes like "diabesity," Dr. Sharlin has expanded his toolbox to offer more comprehensive and effective care.  One of the critical insights from Dr. Sharlin is the role of the gut-brain connection and how gut health can significantly influence brain health, particularly in neurodegenerative diseases. He also delves into the emerging role of mitochondrial dysfunction and oxidative stress as primary drivers of diseases like Parkinson's. Dr. Sharlin emphasises the importance of early intervention and personalised care, recognising that no two patients are the same, even when they have identical diagnoses.

When you listen to an orchestra, the blending of numerous instruments into a harmonious melody is what makes the music truly captivating. While a single instrument can sound wonderful on its own, there is something profoundly powerful and beautiful about the orchestral approach. This concept applies to our school systems as well, where we refer to it as systemic synergy.Welcome back to our esteemed hosts, Kim Yaris, M.Ed., Content Creator/Researcher, and Dr. Jennifer Chevalier, Director of Funding. Together, they offer a sneak peek into what we can expect from this summer's Research Conversations and help define systemic synergy, the main theme of this season. This episode introduces the first of many tools designed to help your school district enhance outcomes for everyone through systemic synergy. Don't miss out on this educational episode!Don't forget to like and subscribe, and turn on those bell notifications so you don't miss our next episode!To take advantage of the tool to help your school's vision click on this link: https://resources.franklincovey.com/c/systemic-synergy-visioning-tool?x=iVcL7yLearn more about academics here:https://www.leaderinme.org/research-highlights-academics/Starring: Kim Yaris, M.Ed, Content Creator/Researcher at FranklinCovey Education Dr. Jennifer Chevalier, Director of Funding at FranklinCovey EducationTime stamps: (00:00 - 00:25) Introduction(00:26 - 04:06) What is Systemic Synergy?(04:07 - 07:12) Improving Outcomes for Everyone(07:13 - 09:29) Maintaining Systemic Synergy(09:30 - 10:57) A Tool to Align Vision(10:58 - 12:26) Looking to the Future(12:27 - 12:51) Closing

When you listen to an orchestra, the blending of numerous instruments into a harmonious melody is what makes the music truly captivating. While a single instrument can sound wonderful on its own, there is something profoundly powerful and beautiful about the orchestral approach. This concept applies to our school systems as well, where we refer to it as systemic synergy.Welcome back to our esteemed hosts, Kim Yaris, M.Ed., Content Creator/Researcher, and Dr. Jennifer Chevalier, Director of Funding. Together, they offer a sneak peek into what we can expect from this summer's Research Conversations and help define systemic synergy, the main theme of this season. This episode introduces the first of many tools designed to help your school district enhance outcomes for everyone through systemic synergy. Don't miss out on this educational episode!Don't forget to like and subscribe, and turn on those bell notifications so you don't miss our next episode!To take advantage of the tool to help your school's vision click on this link:Learn more about academics here:https://www.leaderinme.org/research-highlights-academics/Starring: Kim Yaris, M.Ed, Content Creator/Researcher at FranklinCovey Education Dr. Jennifer Chevalier, Director of Funding at FranklinCovey EducationTime stamps: (00:00 - 00:25) Introduction(00:26 - 04:06) What is Systemic Synergy?(04:07 - 07:12) Improving Outcomes for Everyone(07:13 - 09:29) Maintaining Systemic Synergy(09:30 - 10:57) A Tool to Align Vision(10:58 - 12:26) Looking to the Future(12:27 - 12:51) Closing

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: How can we transform musculoskeletal care to improve outcomes and reduce costs? Our next guest, Rob Cohen, is tackling this challenge and more as CEO of Livara Health. With over two decades of healthcare leadership experience, Rob brings a unique perspective on value-based care and population health management. Previously leading companies like Bamboo Health and Evolent Health, Rob witnessed firsthand the transformative impact of innovative healthcare solutions. While together, Rob shares why he is driven by a passion to make healthcare more connected and sustainable and his vision to reimagine musculoskeletal management through comprehensive care planning, delivery, and navigation. Join us to discover how Livara's purpose-built solutions are enhancing patient experiences, optimizing clinical outcomes, and driving down costs for health plans and providers. Let's go! Episode Highlights:Emphasizes improving healthcare by building on existing strengths rather than total disruptionAddresses musculoskeletal (MSK) spend challenge: $400 billion annually, growing twice as fast as general healthcareOffers comprehensive MSK care: planning, navigation, and delivery to reduce unnecessary proceduresReports significant outcomes: 45% cost reduction, 35% fewer surgeries, 60% less opioid usePredicts future trend: integration of specialty value-based care programs for cohesive patient careAbout our Guest: Rob Cohen is the CEO of Livara Health, a value-based musculoskeletal (MSK) management company providing care planning, care delivery and care navigation to improve outcomes and lower costs for people with MSK conditions.Prior to joining Livara, Rob was the CEO at Bamboo Health, where he led the company's national expansion from 25 states to 45 states and was responsible for rapid revenue growth in new product lines and new market segments. Prior to Bamboo, Rob served as Market President at Evolent Health where he was responsible for market growth and managed the P&L and operations for partnerships with health systems. Prior to Evolent, Rob held leadership roles with Healthways, Wellpoint, The Walt Disney Company, and McKinsey & Company.He is a firm believer in the power of healthcare as a catalyst for positive change and is committed to making a meaningful difference in the lives of others.Links Supporting This Episode:Livara Health Website: CLICK HERERob Cohen LinkedIn page: CLICK HERELivara Health LinkedIn page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form:

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, and guests Michael Cameron, MD, and James Allred, MD, discuss the intersection of GLP-1 agents and dermatology, exploring how these drugs, initially designed for managing type 2 diabetes, are now offering promising benefits for skin conditions associated with obesity. They begin by providing an overview of glucagon-like peptide-1 (GLP-1) agents and their mechanisms of action. These drugs, which include terzepitide (marketed as Mounjaro and Zepbound) and semaglutide (available as Ozempic and Wegovy), are GLP-1 receptor agonists that enhance insulin secretion, reduce appetite, and promote weight loss. Dr Allred then shares his personal experience, noting that patients on GLP-1 therapy, prescribed by their primary care physicians, showed remarkable improvements in their hidradenitis suppurativa (HS) symptoms. Observing these benefits, he began prescribing GLP-1 agents himself. Although randomized controlled trials directly linking GLP-1 agents to HS improvement are lacking, clinical observations align with the understanding that obesity-related systemic inflammation impacts dermatologic conditions like HS and psoriasis. The conversation then shifts to discussing weight management with patients. They stress the importance of empathy and understanding, particularly for patients with HS who may find exercise counterproductive due to flare-ups. By explaining that reducing systemic inflammation through weight loss can significantly improve HS symptoms, they find patients more receptive to GLP-1 therapy. Finally, they cover the practical aspects of integrating GLP-1 prescribing into dermatologic practice. Drs Allred and Cameron advise on patient assessment, including checking BMI and potential contraindications like a history of thyroid cancer. They highlight the importance of monitoring basic labs, such as glucose, hemoglobin A1c, and lipid profiles, to track the therapy's impact and support insurance approvals. Tune in to learn how dermatologists can leverage GLP-1 agents to improve patient outcomes by addressing the inflammatory underpinnings of conditions like HS and enhancing overall quality of life.

Shifting Your Mindset for Success with Dr. Lorenka Joseph, PharmD on 'This Week in Pharmacy' -- It's June 21st, 2024, and it's the Summer Solstice, the Longest Day of the Year occurring when one of Earth's poles is tilted toward the sun at its most extreme angle, and due to Earth's tilt, this happens twice a year.  Thanks to RxMile for sponsoring today's TWIRx, logistics strategies and technology, this software sells itself. With the expansion of long term care at home, and the need for more pharmacy delivery in areas with pharmacy closures, it's time to talk with Kunal and his team. This is a game changer.  NEWS: The New York Times reported on the impact to public health of the PBMs middlement, causing massive struggles for pharmacy care throughout the nation.  Pharmacy closures in Michigan and Ohio causing major concerns for the needs of millions of people.  Maternal Health Disparities, Role of Pharmacists in Improving Outcomes, from Pharmacy Times, interview with Rebeca Snead, PharmD.  Our feature interview with Dr. Lorneka Joseph PharmD, helping healthcare professionals Shift Your Mindset for Success! 

Efficiency in healthcare, like closing care gaps and reducing readmissions, is vastly improved through technological innovation. In this episode, Saul Marquez interviews Yoni Shtein, CEO of Laguna Health, a company revolutionizing care management through automation and technology with a mission to empower care managers with conversational intelligence. By leveraging natural language processing and AI, Laguna streamlines documentation, allowing care managers to focus on patients rather than paperwork, an innovation that, according to Yoni, not only enhances efficiency but also improves patient outcomes, reducing readmissions and optimizing care transitions. He also emphasizes Laguna's unique data set and language model, which differentiate the company in the market. Yoni highlights the significant ROI opportunities for payers, including increased efficiency, effectiveness, and cost savings, and challenges leaders to embrace nuanced thinking in navigating healthcare technology trends to drive better outcomes for patients.  Tune in and learn why building scalable solutions that deliver tangible value to consumers is paramount in today's healthcare landscape! Resources:  Watch the entire interview here. Follow and connect with Yoni Shtein on LinkedIn. Learn more about Laguna Health on their LinkedIn and website.

Send us a Text Message.Dr. Trillitye Paullin is a molecular biologist and founder of Free to Feed, a consultation service for navigating infant food reactivity in breastfeeding dyads. Today, Dr. Trill joins us with one of her clients, Chelsea, a first-time mom who found Trill and our podcast and reached out to help spread the research around newborn food reactivity. Trill shares her ground-breaking research into why and how a mother's diet causes allergic responses in babies in the form of bloody stools, skin rashes, vomiting, reflux and colic-like symptoms. With around 25% of parents reporting food allergy symptoms in their babies, these issues have been grossly underserved and misunderstood for decades. We cover: The top 12 foods causing allergy symptoms;The timing of protein transfer, reactivity, and gut healing;How our gastrointestinal health impacts infant food allergies;How stress and cortisol impact the transfer of proteins into milk.Stanford University and Free to Feed have embarked on a transformative partnership to develop tools aimed at accurately identifying and managing pediatric food allergies. This collaboration, part of the "Improving Outcomes for Food-Allergic Children" project led by Dr. Trillitye Paullin and supported by Stanford's Data Science for Social Good Program, seeks to enhance care quality while preventing unnecessary dietary restrictions for children. By integrating these tools into clinical practice and fostering enhanced awareness among providers, the initiative promises to improve health outcomes for children and provide significant insights into the complexities of food allergies, shaping future policies in pediatric healthcare.**********Down to Birth is sponsored by:Vitality: An athleisure brand made for women, by women, designed with style and comfort for pregnancy and beyond.Davin & Adley-- The perfect nursing and pumping bra combinedSilverette Nursing Cups -- Soothe and heal sore nipples with 925 silver nursing cups.Postpartum Soothe -- Herbs and padsicles to heal and comfort.Needed -- For before, during, and after pregnancy.Use promo code: DOWNTOBIRTHDrinkLMNT -- Purchase LMNT with this unique link and get a free 8-day supply.Connect on Patreon for our exclusive content.Email Contact@DownToBirthShow.comInstagram @downtobirthshow802-GET-DOWNWork with Cynthia:203-952-7299HypnoBirthingCT.comWork with Trisha:734-649-6 Connect with us on Patreon for our exclusive content.Email Contact@DownToBirthShow.comInstagram @downtobirthshowCall us at 802-GET-DOWN Work with Cynthia: 203-952-7299 HypnoBirthingCT.com Work with Trisha: 734-649-6294 Please remember we don't provide medical advice. Speak to your licensed medical provider for all your healthcare matters.

This week's guest is in the business of maximizing outcomes.A self-described "reformed investment banker", Daniel Etra is the co-founder and CEO of Rethink, a data-driven company changing the face of neurodivergent care.He talks passionately about the vast social impact of their operations, teaching frontline clinicians, empowering caregivers, and helping neurodivergent individuals reach their potential.With their library of educational videos, cutting-edge Al tools and enormous dataset, Rethink are a modern company with global aims - centering inclusion and empowerment at the core of their ethos.Let's get started!Follow me on Instagram and Facebook @ericfethkemd and checkout my website at www.EricFethkeMD.com. My brand new book, The Privilege of Caring, is out now on Amazon! https://www.amazon.com/dp/B0CP6H6QN4

Dr. Chuck Thigpen, Senior Vice President for Clinical Excellence at ATI, as we talk about the pivotal role of physical therapy in healthcare. We explore the Department of Defense's recent acknowledgment of physical therapists as primary care providers and what it means for the future of musculoskeletal (MSK) care.We had to start by congratulating Chuck on his recent induction into the Academy of Sports Physical Therapy Hall of Fame.Key Message:Physical therapy stands at the forefront of healthcare for MSK pain, offering a fundamental and essential approach to overall health akin to primary care. With the military setting a precedent, it's time to recognize and utilize PT for its safe, effective, and cost-efficient benefits in the general population.Supporting Points: Safety and Efficacy of PT: Discover how physical therapy serves as a reliable and effective first course of treatment for MSK issues, setting the stage for a healthier future. Improving Outcomes and Reducing Costs: Learn about the tangible benefits of choosing PT first, including enhanced patient outcomes and significant cost savings in healthcare. Military Endorsement as a Benchmark: If the military, with its rigorous standards and focus on optimal performance, trusts in PT as a primary care solution, why shouldn't we? Explore how this endorsement is a game-changer for public healthcare perceptions.Opportunity to Lead: This episode also highlights ATI's leadership in the physical therapy profession, demonstrating the organization's commitment to advancing healthcare. From the vast resources and experience ATI harnesses to deliver unparalleled care, to creating an engaging and supportive work environment, discover why ATI is not just a leader in physical therapy but also an exemplary place to work and collaborate.Chuck also gives more insight on a recent announcement from ATI on the topic of expanding research reach, ATI unveiled iMSKA, "iMSKA is dedicated to progressing quality clinical care with a focus on research. The institute was established to offer long-lasting and ongoing contributions to the growing body of scientific knowledge and evidence in the management of patients with MSK conditions." More information here, https://i-mska.org/Dr. Thigpen brings a wealth of knowledge, backed by his extensive experience and the innovative practices at ATI, to shed light on how direct access to physical therapy is reshaping healthcare for the better. Whether you're a healthcare professional, someone experiencing MSK pain, or simply interested in the future of healthcare, this episode offers valuable insights into the evolving landscape of physical therapy as a primary care service.Have you ever thought about where your career in physical therapy could take you? It's not just about the job; it's about making real connections that help patients get better faster. Imagine working somewhere you can grow through mentorship, and get leadership training that matters.Sounds like a place you'd fit right in? Click to find out more about what working with ATI is really like. And let's make a difference together.

Joining host Chadi is a trio of esteemed guests – Drs. Andy Evans, Matt Maurer, and Susan Parsons – of the HoLISTIC (Hodgkin Lymphoma International Study for Individual Care) Consortium. In this riveting conversation, they delve into the consortium's pioneering efforts, bringing together an international team of experts to scrutinize the multifaceted dimensions of Hodgkin lymphoma, spanning prognosis, epidemiology, treatment, survivorship, and health outcomes across all age groups. The discussion circles around consensus protocols for treatment, referral pathways, and clinical trials, probing the necessity of transplants in the era of novel therapeutics and the creation of predictive models tailored to individual patient needs. Tune in to hear about the meticulous efforts invested in building the HoLISTIC portal, automating data migration, and navigating the challenges and progress in predictive modeling for treatment selection, response, and failure. This episode offers a captivating exploration of how collaboration, technology, and data analysis converge to shape the future of Hodgkin lymphoma care. Find out more about the HoLISTIC Consortium. https://www.hodgkinconsortium.com/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA